Molecular Basis of Bioelectronic Medicine

生物电子医学的分子基础

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Inflammation, mediated by the immune response to infection and sterile injury, is a major underlying cause of disease. Advances in understanding the molecular mechanisms of inflammation hold promise for developing future therapies for severe sepsis, shock, ischemia reperfusion injury, autoimmune diseases, and other debilitating diseases of national importance. Research supported by the NIGMS in the principle investigator's lab has revealed mechanisms to control inflammation by identifying and targeting specific cytokines, and by mapping and targeting specific neural circuits that control their activity. This work has now progressed to launching a new field, termed "bioelectronic medicine," which holds promise as strategy to develop therapies using electronic devices to target anti-inflammatory neural circuits. The present proposal seeks to understand unanswered questions about the molecular mechanisms controlling inflammation as derived from three existing RO1 funded projects in the PI's laboratory. The first is to understand the identity and mechanisms of the reflex neural circuits that control immune responses. The second is to understand the biology of cytokine mediators of inflammation that are necessary and sufficient for disease causation. And the third is to understand the molecular mechanisms that regulate cytokine release under the influence of neurotransmitters, including regulation of cytokine gene expression and inflammasome activity. The successful completion of this work will provide significant new data necessary to develop therapeutic modalities for the prevention and treatment of inflammation using bioelectronic devices.
 描述(申请人提供):炎症,由对感染和无菌损伤的免疫反应调节,是疾病的主要潜在原因。了解炎症的分子机制的进展有望为未来开发严重脓毒症、休克、缺血再灌注损伤、自身免疫性疾病和其他国家重要的衰弱疾病的治疗方法。由NIGMS在首席研究员实验室支持的研究揭示了通过识别和靶向特定细胞因子,以及通过映射和靶向控制其活动的特定神经回路来控制炎症的机制。这项工作现在已经进展到启动一个新的领域,被称为“生物电子医学”,它有望成为开发使用电子设备靶向抗炎神经回路的治疗方法的战略。目前的提案试图了解关于控制炎症的分子机制的悬而未决的问题,这些问题来自于PI实验室现有的三个RO1资助的项目。首先是了解控制免疫反应的反射神经回路的身份和机制。第二是了解炎症的细胞因子介质的生物学,这些介质对于疾病的病因是必要的和充分的。三是了解神经递质影响下细胞因子释放的分子机制,包括细胞因子基因表达和炎症体活性的调节。这项工作的成功完成将为开发使用生物电子设备预防和治疗炎症的治疗方式提供必要的重要新数据。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kevin J Tracey其他文献

Regulating innate immunity with dopamine and electroacupuncture
用多巴胺和电针调节先天免疫
  • DOI:
    10.1038/nm.3501
  • 发表时间:
    2014-03-04
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Sangeeta S Chavan;Kevin J Tracey
  • 通讯作者:
    Kevin J Tracey
Neural regulation of immunity: molecular mechanisms and clinical translation
免疫的神经调节:分子机制与临床转化
  • DOI:
    10.1038/nn.4477
  • 发表时间:
    2017-01-16
  • 期刊:
  • 影响因子:
    20.000
  • 作者:
    Valentin A Pavlov;Kevin J Tracey
  • 通讯作者:
    Kevin J Tracey
It takes nerve to dampen inflammation
抑制炎症需要勇气。
  • DOI:
    10.1038/ni0805-756
  • 发表时间:
    2005-08-01
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Christine N Metz;Kevin J Tracey
  • 通讯作者:
    Kevin J Tracey
From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies?
从小鼠到人类:或者我们对基于细胞因子的抗炎疗法了解了什么?
  • DOI:
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Kevin J Tracey;Edward Abraham
  • 通讯作者:
    Edward Abraham
Tumor necrosis factor in the malnutrition (cachexia) of infection and cancer.
感染和癌症营养不良(恶病质)中的肿瘤坏死因子。

Kevin J Tracey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kevin J Tracey', 18)}}的其他基金

Molecular basis of bioelectronic medicine
生物电子医学的分子基础
  • 批准号:
    10394188
  • 财政年份:
    2016
  • 资助金额:
    $ 71.78万
  • 项目类别:
Molecular basis of bioelectronic medicine
生物电子医学的分子基础
  • 批准号:
    10614430
  • 财政年份:
    2016
  • 资助金额:
    $ 71.78万
  • 项目类别:
Molecular Basis of Bioelectronic Medicine
生物电子医学的分子基础
  • 批准号:
    9071799
  • 财政年份:
    2016
  • 资助金额:
    $ 71.78万
  • 项目类别:
Molecular Basis of Bioelectronic Medicine
生物电子医学的分子基础
  • 批准号:
    9906903
  • 财政年份:
    2016
  • 资助金额:
    $ 71.78万
  • 项目类别:
PKR mediated inflammasome activation and pyroptosis in sepsis
脓毒症中 PKR 介导的炎症小体激活和细胞焦亡
  • 批准号:
    8496322
  • 财政年份:
    2014
  • 资助金额:
    $ 71.78万
  • 项目类别:
Central cholinergic regulation of inflammation
炎症的中枢胆碱能调节
  • 批准号:
    8338817
  • 财政年份:
    2011
  • 资助金额:
    $ 71.78万
  • 项目类别:
Central cholinergic regulation of inflammation
炎症的中枢胆碱能调节
  • 批准号:
    8042116
  • 财政年份:
    2011
  • 资助金额:
    $ 71.78万
  • 项目类别:
Macrophage Inactivation in Sepsis after Shock or Trauma
休克或创伤后脓毒症中巨噬细胞失活
  • 批准号:
    7933295
  • 财政年份:
    2009
  • 资助金额:
    $ 71.78万
  • 项目类别:
VAGUS NERVE STIMULATION IN RHEUMATOID ARTHRITIS (VANSRA)
迷走神经刺激治疗类风湿性关节炎 (VANSRA)
  • 批准号:
    7951920
  • 财政年份:
    2009
  • 资助金额:
    $ 71.78万
  • 项目类别:
CHOLINERGIC MODULATION OF CYTOKINE SYNTHESIS IN SEPSIS SURVIVORS
脓毒症幸存者细胞因子合成的胆碱能调节
  • 批准号:
    7719247
  • 财政年份:
    2008
  • 资助金额:
    $ 71.78万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
  • 批准号:
    23H02155
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
    Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
  • 批准号:
    10788032
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
  • 批准号:
    23K14742
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
  • 批准号:
    10593224
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
  • 批准号:
    10864719
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
  • 批准号:
    10586562
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
  • 批准号:
    23K06589
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
  • 批准号:
    10623380
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
  • 批准号:
    10735148
  • 财政年份:
    2023
  • 资助金额:
    $ 71.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了